|
EFHA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.308300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.589800E-02 |
| Normal-vs-Stage2 |
4.651200E-01 |
| Normal-vs-Stage3 |
9.755600E-03 |
| Normal-vs-Stage4 |
5.431700E-04 |
| Stage1-vs-Stage2 |
5.983000E-01 |
| Stage1-vs-Stage3 |
1.286380E-01 |
| Stage1-vs-Stage4 |
9.876400E-03 |
| Stage2-vs-Stage3 |
1.571990E-01 |
| Stage2-vs-Stage4 |
2.700200E-02 |
| Stage3-vs-Stage4 |
3.347200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.246300E-02 |
| Normal-vs-AfricanAmerican |
4.590600E-01 |
| Normal-vs-Asian |
3.595800E-02 |
| Caucasian-vs-AfricanAmerican |
5.643000E-01 |
| Caucasian-vs-Asian |
8.438600E-01 |
| AfricanAmerican-vs-Asian |
5.687600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.135800E-03 |
| Normal-vs-Female |
9.406500E-02 |
| Male-vs-Female |
1.851740E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.566170E-01 |
| Normal-vs-Age(41-60Yrs) |
2.400500E-02 |
| Normal-vs-Age(61-80Yrs) |
5.620200E-03 |
| Normal-vs-Age(81-100Yrs) |
3.575000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.073800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.124100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.166000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.376600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.536200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.673200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.909780E-01 |
| Classical-VS-Follicular |
8.259800E-01 |
| Classical-VS-Other |
2.658400E-01 |
| Classical-VS-Normal |
1.415790E-01 |
| Tall-VS-Follicular |
3.869600E-01 |
| Tall-VS-Other |
6.963600E-01 |
| Tall-VS-Normal |
2.873600E-02 |
| Follicular-VS-Other |
4.173200E-01 |
| Follicular-VS-Normal |
1.638990E-01 |
| Other-VS-Normal |
6.722300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.730000E-02 |
| Normal-vs-N1 |
2.203400E-04 |
| N0-vs-N1 |
3.101900E-02 |
|
|
